U.S. House Calls Market Size, Share & Trends Analysis Report By Service (Primary Care, Urgent Care, Preventive Care, Mobile Clinical Testing, Chronic care Management) - Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

The U.S. house calls market size was exhibited at USD 637.70 million in 2023 and is projected to hit around USD 1,102.78 million by 2033, growing at a CAGR of 5.63% during the forecast period 2024 to 2033.

Key Takeaways:

• In 2023, the primary care segment held the largest market share of 27.45%. 
• The highest growth with a CAGR of 6.04% during the forecast period.

Market Overview

The U.S. House Calls Market has undergone a transformative revival in the modern healthcare ecosystem, shifting from a traditional model of medical practice to a scalable, tech-enabled service offering critical healthcare at the patient’s doorstep. While house calls were once a relic of the mid-20th century, today they are experiencing a strong resurgence due to the demand for patient-centric, accessible, and cost-effective care. The market is now characterized by a dynamic blend of independent practitioners, concierge medical services, app-based healthcare providers, and hospital-affiliated home visit programs.

The growth of this market is largely driven by aging populations, chronic disease prevalence, post-pandemic behavioral shifts, and increased interest in decentralized care delivery. Particularly for elderly, immobile, or immunocompromised patients, house calls offer a safer, more convenient alternative to traditional clinical settings. At the same time, mobile medical services are increasingly being sought after by busy professionals, parents of young children, and tech-savvy urban populations. This resurgence has also been facilitated by advancements in telehealth, mobile diagnostics, and portable medical equipment, allowing for a full suite of medical services to be rendered at home.

Health systems and payers have begun to embrace house call models for their potential to reduce emergency room visits, hospital readmissions, and total cost of care. Value-based care initiatives and reimbursement flexibility from CMS and private insurers have further legitimized the house calls model as a scalable alternative for chronic care and primary care services. As the U.S. moves toward a more patient-driven, distributed healthcare model, the house calls market is poised to become a key pillar of the broader care continuum.

Report Scope of The U.S. House Calls Market

Market Driver: Aging Population and Demand for In-Home Chronic Care

One of the most significant drivers of the U.S. House Calls Market is the aging population and its associated healthcare needs. As of 2025, over 56 million Americans are aged 65 or older, many of whom live with chronic conditions such as diabetes, heart failure, COPD, and arthritis. Traditional clinical environments often pose logistical and emotional challenges for these patients, who may struggle with mobility, cognitive impairments, or immunocompromised conditions.

House calls offer a powerful solution by delivering care directly to the patient’s home, thereby minimizing stress, reducing transportation costs, and improving adherence to treatment. These services are especially effective for chronic care management, medication reconciliation, post-discharge follow-ups, and behavioral health interventions. Providers such as Heal, DispatchHealth, and Landmark Health have demonstrated cost savings and improved patient satisfaction through tailored in-home visits. As healthcare shifts toward outcomes and prevention, house calls are becoming indispensable in meeting the long-term needs of older Americans.

Market Restraint: Workforce Limitations and Scalability Challenges

Despite its promise, the U.S. House Calls Market faces significant challenges related to workforce limitations and scalability. Delivering medical services in a decentralized, home-based model requires a highly coordinated team of physicians, nurse practitioners, physician assistants, and mobile diagnostic staff. Unlike in centralized clinical settings, these professionals must travel, adapt to different environments, and often work independently with limited backup support.

This unique service model also demands efficient routing, scheduling, and time management, all of which can be difficult to scale across geographic regions. Furthermore, while demand is growing, there remains a shortage of medical professionals trained and willing to provide house calls, especially in rural or underserved areas. Without addressing workforce pipeline and training issues, the market risks bottlenecks in service delivery and quality inconsistency, especially as consumer expectations continue to rise.

Market Opportunity: Expansion of Mobile Diagnostic and Testing Capabilities

One of the most compelling opportunities in the house calls market is the expansion of mobile clinical testing and diagnostics. Recent advancements in portable medical equipment including mobile X-rays, EKGs, ultrasounds, rapid blood tests, and wearable monitors have transformed the scope of care that can be administered in the home. What was once limited to basic physical exams and medication delivery now encompasses full diagnostic workups, enabling providers to make faster, more informed decisions on-site.

For example, companies like DispatchHealth and Sprinter Health deploy mobile units equipped to conduct lab draws, imaging, and biomarker tests, all while maintaining clinical accuracy and regulatory compliance. This significantly reduces the need for hospital or lab visits, especially for elderly or high-risk patients. As costs decline and diagnostic miniaturization improves, mobile testing capabilities will unlock new levels of care accessibility and efficiency, creating massive opportunities for growth and differentiation in the house calls market.

U.S. House Calls Market By Service Insights

Primary Care dominated the U.S. house calls market, owing to the breadth of services it covers and its role as the foundation of long-term patient-provider relationships. In-home primary care includes physical exams, medication management, chronic disease monitoring, lifestyle counseling, and diagnostic testing. Elderly patients, those with mobility issues, and families with young children are among the most common recipients of these services. Providers that specialize in home-based primary care often build longitudinal patient relationships, enhancing trust and improving continuity of care. The ability to deliver holistic, patient-centered care in familiar surroundings contributes to high satisfaction rates and reduced hospitalizations.

Mobile Clinical Testing is projected to be the fastest-growing segment, driven by the demand for convenience, accuracy, and immediate results. This segment includes services such as mobile blood draws, point-of-care testing, imaging services, COVID-19 testing, and advanced diagnostics delivered at the patient’s home. The rapid expansion of mobile diagnostics is particularly beneficial for high-risk populations who would otherwise face significant barriers in accessing care. As technology continues to advance, and as insurers expand coverage for home-based testing, this segment is expected to play a critical role in preventative care, chronic condition management, and rapid response to acute symptoms.

Country-Level Analysis

Across the United States, the resurgence of house calls is being driven by urban tech innovation and rural access needs alike. In metropolitan areas like New York, Los Angeles, and San Francisco, app-based platforms have made it easier for patients to request house calls in real-time, while concierge services cater to high-income clients seeking on-demand care. Conversely, in rural America, house calls are being revived as a means to address healthcare access gaps where hospital closures and clinician shortages are prevalent.

Public health agencies and Medicare Advantage plans are increasingly investing in home-based care as a strategic approach to reduce ER overuse and support aging-in-place initiatives. Pilot programs by the Department of Veterans Affairs and CMS Innovation Center are funding house call models that serve frail elders, patients with advanced illness, and those recently discharged from hospitals. As more states revise telemedicine laws and value-based reimbursement expands, house calls are poised to scale more uniformly across the country.

Some of the prominent players in the U.S. house calls market include:

• SOS Doctors House Calls, Inc
• Heal
• Doctor on Demand, Inc
• Resurgia Health Solutions LLC
• MDLIVE, Inc
• House Call Doctors Loss Angeles
• Mount Sinai Visiting Doctors
• Visiting Physician Association
• Urgent Med Housecalls
• House Call Doctors Medical Group 

Recent Developments

• DispatchHealth (March 2025): Announced the national expansion of its mobile diagnostic platform, now covering over 50 cities with fully equipped in-home medical units.

• Heal (January 2025): Launched a new senior-focused program offering hybrid virtual and in-person care with 24/7 medical concierge access.

• Sprinter Health (February 2025): Secured $50 million in Series C funding to scale mobile lab testing and biometric data collection services.

• Amazon Clinic (December 2024): Entered the home health market by piloting an Alexa-powered house call scheduling tool integrated with wearable data.

• Landmark Health (November 2024): Partnered with a leading Medicare Advantage provider to expand house call services for chronically ill seniors in underserved regions.

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global U.S. house calls market.

Service

• Primary Care
• Urgent Care
• Preventive Care
• Mobile Clinical Testing
• Chronic Care Management
• Others